And So It Begins: House Energy and Commerce Leaders Unveil FDA User Fees Legislative Package | King & Spalding

On May 4, 2022, House Energy and Commerce (“E&C”) Committee leaders unveiled the legislative package to reauthorize the U.S. Food and Drug Administration (“FDA” or the “Agency”) user...

Related Keywords

United States ,Eva Temkin Jonathan Trinh ,Eric Henry ,Eva Temkin ,Frank Pallone Jr ,Dec Committee ,Genus Medical Technologies ,Health Subcommittee ,Device Manufacturer Communications With Payors ,Drug Administration ,House Energy ,Commerce Ec Committee ,Eagle Pharms Inc ,Drug Administration Safety ,Radiological Health ,Seedepomed Inc ,European Union Mutual Recognition Agreement ,Senate Health ,Us Dept Of Health Human Servs ,Accelerated Approval ,Prescription Drug User Fee Act ,Medical Device User Fee Act ,Generic Drug User Fee Act ,Biosimilar User Fee Act ,House Draft ,Frank Pallone ,Improve Enrollment ,Underrepresented Racial ,Ethnic Subgroups ,Clinical Trials ,Improving Diversity ,Records Requests ,Drug Exclusivity ,Orphan Drug ,Eleventh Circuit ,Federal Register ,New Drug Applications ,Abbreviated New Drug Applications ,Orange Book ,Biological Product Patent Transparency ,Consolidated Appropriations Act ,Biologics License Applications ,Purple Book ,World Evidence ,Century Cures ,Real World Evidence ,Support Regulatory Decision Making ,Medical Devices ,Drug Amendments ,Press Release ,Fees Legislative Package ,Personal Care Products Safety Act ,Pink Sheet ,Feel Bill Include ,Woodcok Bemoans Lack ,Accurate Leading Edge ,Innovation Act ,Drug Admin ,Expedited Programs ,Serious Conditions ,Expedited Programs Guidance ,Human Prescription Drug ,Biological Products Approved Under ,Accelerated Approval Regulatory Pathway ,Jonathan Trinh ,Approval Pathway ,Rare Disease Perspective ,Approval Integrity Act ,Draft Guidance ,Diversity Plans ,Participants From Underrepresented Racial ,Ethnic Populations ,Client Alert ,Pandemic Silver Lining ,Using Digital Health Technologies ,Clinical Investigations ,Resiliency Roadmap ,Mutual Recognition Agreement ,Frequently Asked Questions ,Human Servs ,Eagle Pharms ,Regulate Devices ,United States Food ,Certain Ophthalmic Products ,Policy Regarding Compliance With ,Appropriations Act ,Biological Product Patent Transparency Act ,Century Cures Act ,Magic Mixing Cauldron ,Medical Device Regulatory Decisions ,Formulary Committees ,Similar Entities Questions ,Quality System Considerations ,Premarket Submissions ,